Zymeworks Inc
Change company Symbol lookup
Select an option...
ZYME Zymeworks Inc
GPC Genuine Parts Co
VENA Venus Acquisition Corp
VECO Veeco Instruments Inc
IGTAU Inception Growth Acquisition Ltd
BAC-K Bank of America Corp
FAX abrdn Asia-Pacific Income Fund Inc
HIIIU Hudson Executive Investment Corp III
PMVP PMV Pharmaceuticals Inc
GER Goldman Sachs MLP and Energy Renaissance Fund
Go

Health Care : Biotechnology | Small Cap Value
Based in Canada
Company profile

Zymeworks Inc. is a clinical-stage biopharmaceutical company that is engaged in the discovery, development, and commercialization of bio-therapeutics for the treatment of cancer. Its lead product candidate is zanidatamab, a bispecific antibody that targets two distinct domains of the human epidermal growth factor receptor 2 (HER2). Its product candidate ZW49, combines the design of zanidatamab with its ZymeLink ADC platform, comprised of its cytotoxin and cleavable linker. The Company operates through a number of platforms, including Azymetric, ZymeLink, EFECT and ProTECT. Its Azymetric is a bispecific platform that enables therapeutic antibodies to simultaneously bind multiple distinct locations on a target or to multiple targets. Its ZymeLink, which is an antibody-drug conjugate (ADC) platform comprised of cytotoxins and the linker technology used to couple these cytotoxins to tumor-targeting antibodies or proteins.

Closing Price
$5.27
Day's Change
-0.06 (-1.13%)
Bid
--
Ask
--
B/A Size
--
Day's High
5.36
Day's Low
5.09
Volume
(Average)
Volume:
451,814

10-day average volume:
478,798
451,814
  • Prev Close
    5.33
  • Today's Open
    5.25
  • Day's Range
    5.09-5.36
  • Avg Vol (10-day)
    478.8K
  • Last (time)
    7:00p ET 09/23/22
  • Last (size)
    3
  • 52-Wk Range
    4.11 - 31.70
    LowHigh
  • (09/23/21 - 09/07/22)
    28.22%
  • 88.4%
  • Market Cap
    325.1M
  • Shares Outstanding
    61.7M
  • -4.09
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.1
  • 75.56
  • (% of float 08/31/22)
    13.78

Latest News

September 16, 2022
8:30 am ET
BusinessWire
September 12, 2022
4:15 pm ET
BusinessWire
September 08, 2022
4:15 pm ET
BusinessWire
September 04, 2022
6:05 pm ET
BusinessWire
August 04, 2022
4:15 pm ET
BusinessWire
August 01, 2022
8:30 am ET
BusinessWire
July 25, 2022
8:30 am ET
BusinessWire
July 22, 2022
8:30 am ET
BusinessWire
July 21, 2022
8:30 am ET
BusinessWire
July 15, 2022
8:00 am ET
BusinessWire
June 27, 2022
8:30 am ET
BusinessWire
May 29, 2022
8:54 am ET
MarketWatch
May 20, 2022
9:53 am ET
MarketWatch
April 13, 2022
7:06 am ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.